PT  - JOURNAL ARTICLE
AU  - Mucha, Simon R.
AU  - Dugar, Siddharth
AU  - McCrae, Keith
AU  - Joseph, Douglas
AU  - Bartholomew, John
AU  - Sacha, Gretchen L.
AU  - Militello, Michael
TI  - Coagulopathy in COVID-19: Manifestations and management
AID  - 10.3949/ccjm.87a.ccc024
DP  - 2020 Aug 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 461--468
VI  - 87
IP  - 8
4099  - http://www.ccjm.org/content/87/8/461.short
4100  - http://www.ccjm.org/content/87/8/461.full
SO  - Cleve Clin J Med2020 Aug 01; 87
AB  - Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings of severe COVID-19– associated coagulopathy. Prophylaxis against venous thromboembolism is paramount for all hospitalized patients, with more aggressive prophylaxis and screening recommended for patients with D-dimer levels above 3.0 μg/mL. Point-of-care ultrasonography is the imaging method of choice for patients at high risk, as it entails minimal risk of exposing providers to the virus.